TY - JOUR
T1 - Long-term outcome of transoral organ-preserving pharyngeal endoscopic resection for superficial pharyngeal cancer
AU - Muto, Manabu
AU - Satake, Hironaga
AU - Yano, Tomonori
AU - Minashi, Keiko
AU - Hayashi, Ryuichi
AU - Fujii, Satoshi
AU - Ochiai, Atsushi
AU - Ohtsu, Atsushi
AU - Morita, Shuko
AU - Horimatsu, Takahiro
AU - Ezoe, Yasumasa
AU - Miyamoto, Shinichi
AU - Asato, Ryo
AU - Tateya, Ichiro
AU - Yoshizawa, Akihiko
AU - Chiba, Tsutomu
N1 - Funding Information:
DISCLOSURE: Dr Muto was supported in part by grants-in-aid for cancer research from the Ministry of Health (H21-1), Labor, and Welfare of Japan . The other authors disclosed no financial relationships relevant to this publication.
PY - 2011/9
Y1 - 2011/9
N2 - Background: Early detection of pharyngeal cancer has been difficult. We reported that narrow-band imaging (NBI) endoscopy can detect superficial pharyngeal cancer, and these lesions can be treated endoscopically. Objective: To assess the safety and long-term efficacy of transoral organ-preserving pharyngeal endoscopic resection (TOPER) for superficial pharyngeal cancer. Design and Setting: Retrospective 2-center cohort study. Patients: The study included 104 consecutive patients with superficial pharyngeal cancer. Intervention: TOPER with the patients under general anesthesia. Main Outcome Measurements: Safety of the procedure, long-term survival, clinical outcome. Results: A total of 148 consecutive lesions were resected in 104 patients. There was no severe adverse event. Temporary tracheostomy was required in 17 patients (16%) to prevent airway obstruction. The median fasting period and hospital stay after TOPER were 2 days (range 1-20 days) and 8 days (range 3-58 days), respectively. Ninety-six patients (92%) had no local recurrence or distant metastases. Local recurrence at the primary site developed in 6 patients, but all were resolved by repeat TOPER. With a median follow-up period of 43 months (range 3-96 months), the overall survival rate at 5 years was 71% (95% CI, 59-82). Cause-specific survival rate at 5 years was 97% (95% CI, 93-100). The cumulative development rate of multiple cancers in pharyngeal mucosal sites at 5 years was 22% (95% CI, 12-33). The pharynx was preserved in all patients, and they experienced no loss of function. Limitation: Retrospective design. Conclusions: Peroral endoscopic resection of superficial pharyngeal cancer is a feasible and effective treatment with curative intent.
AB - Background: Early detection of pharyngeal cancer has been difficult. We reported that narrow-band imaging (NBI) endoscopy can detect superficial pharyngeal cancer, and these lesions can be treated endoscopically. Objective: To assess the safety and long-term efficacy of transoral organ-preserving pharyngeal endoscopic resection (TOPER) for superficial pharyngeal cancer. Design and Setting: Retrospective 2-center cohort study. Patients: The study included 104 consecutive patients with superficial pharyngeal cancer. Intervention: TOPER with the patients under general anesthesia. Main Outcome Measurements: Safety of the procedure, long-term survival, clinical outcome. Results: A total of 148 consecutive lesions were resected in 104 patients. There was no severe adverse event. Temporary tracheostomy was required in 17 patients (16%) to prevent airway obstruction. The median fasting period and hospital stay after TOPER were 2 days (range 1-20 days) and 8 days (range 3-58 days), respectively. Ninety-six patients (92%) had no local recurrence or distant metastases. Local recurrence at the primary site developed in 6 patients, but all were resolved by repeat TOPER. With a median follow-up period of 43 months (range 3-96 months), the overall survival rate at 5 years was 71% (95% CI, 59-82). Cause-specific survival rate at 5 years was 97% (95% CI, 93-100). The cumulative development rate of multiple cancers in pharyngeal mucosal sites at 5 years was 22% (95% CI, 12-33). The pharynx was preserved in all patients, and they experienced no loss of function. Limitation: Retrospective design. Conclusions: Peroral endoscopic resection of superficial pharyngeal cancer is a feasible and effective treatment with curative intent.
UR - http://www.scopus.com/inward/record.url?scp=80052262701&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80052262701&partnerID=8YFLogxK
U2 - 10.1016/j.gie.2011.04.027
DO - 10.1016/j.gie.2011.04.027
M3 - Article
C2 - 21704994
AN - SCOPUS:80052262701
SN - 0016-5107
VL - 74
SP - 477
EP - 484
JO - Gastrointestinal endoscopy
JF - Gastrointestinal endoscopy
IS - 3
ER -